H35.3190 Nonexudative age-related macular degeneration, unspecified eye, stage unspecified

Name of the Condition

• Nonexudative Age-Related Macular Degeneration, Unspecified Eye, Stage Unspecified

Summary

Nonexudative age-related macular degeneration (AMD) is a chronic eye condition affecting the macula, the central part of the retina responsible for sharp central vision. It is characterized by gradual macular degeneration without fluid leakage or bleeding, leading to blurred or reduced vision. This form of AMD is also commonly referred to as "dry AMD." The unspecified eye and stage indicate that the condition is not localized to a specific eye or categorized by its progression level.

Causes

The exact cause of nonexudative AMD is not fully understood, but it involves the degeneration of retinal cells and the accumulation of drusen (yellow deposits) under the retina. Oxidative stress and inflammation in retinal tissues are also believed to contribute to the condition.

Risk Factors

• Increasing age, especially over 50.
• Family history of macular degeneration.
• Smoking and tobacco use.
• Obesity and high cholesterol.
• Lack of exercise and poor diet lacking antioxidants and zinc.

Symptoms

• Blurred or reduced central vision.
• Difficulty recognizing faces or reading.
• Need for brighter lighting when working or reading.
• Haziness in overall vision.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilation, to assess the macula. Optical coherence tomography (OCT) is used to visualize retinal layers, and an Amsler grid test detects vision distortions. Fundus photography may document drusen and retinal changes. The unspecified stage and eye indicate that detailed staging or localization was not performed or documented.

Treatment Options

Treatment focuses on slowing progression and managing symptoms. Options include antioxidant vitamin supplements (e.g., vitamins C, E, zinc, and beta-carotene), lifestyle modifications (e.g., smoking cessation, diet changes), and regular monitoring. No treatments can reverse existing damage, but early intervention may preserve vision.

Prognosis and Follow-Up

Nonexudative AMD typically progresses slowly, and vision loss is gradual. Regular follow-up with an eye care provider is essential to monitor for changes, as some cases may convert to the more severe exudative form. Prognosis depends on the rate of progression and response to interventions.

Complications

Potential complications include progression to exudative (wet) AMD, which involves abnormal blood vessel growth and fluid leakage, leading to more rapid vision loss. Other risks include difficulty with daily tasks requiring central vision, such as reading or driving.

Lifestyle & Prevention

• Maintain a diet rich in leafy greens, fish, and antioxidants.
• Avoid smoking and limit alcohol consumption.
• Protect eyes from UV light with sunglasses.
• Exercise regularly to support overall health.
• Monitor vision with an Amsler grid and report changes promptly.

When to Seek Professional Help

Seek care if you experience sudden vision changes, increased blurriness, or distortion, as these may indicate progression to exudative AMD or other eye conditions. Regular eye exams are recommended for those at risk, even if symptoms are mild.

Tips for Medical Coders

This code (H35.3190) is used for nonexudative AMD when the eye and stage are unspecified. Documentation should reflect the absence of eye specification and stage details. Ensure the record supports the diagnosis and lack of further classification to justify the unspecified codes.